ClinicalTrials.Veeva

Menu

Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis

M

Mansoura University Hospital

Status

Completed

Conditions

Brucellosis

Treatments

Diagnostic Test: MoCA

Study type

Observational

Funder types

Other

Identifiers

NCT04301752
Mansoura University 13

Details and patient eligibility

About

Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries.

Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations.

Full description

Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries.

Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations.

The aimed is to shed light to the obscure areas of diagnosis in neurobrucellosis and have detailed general and neurologic features

Enrollment

82 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients >18 years of age with laboratory-confirmed brucellosis

Exclusion criteria

  • Previous neuropsychiatric disease

Trial design

82 participants in 2 patient groups

Neurobrucellosis
Description:
Brucellosis associated with neuropsychiatric manifestations
Treatment:
Diagnostic Test: MoCA
Non-neurobrucellosis
Description:
Brucellosis not associated with neuropsychiatric manifestations
Treatment:
Diagnostic Test: MoCA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems